ScienceDaily (Apr. 14, 2008) — Compounds known as "HDAC inhibitors" exhibit cancer-killing activities in cultured cells. While they are currently being tested as anti-cancer agents in clinical trials, just how they execute their effects is unclear.
Read More
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment